查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999343

全球括约肌成形术市场：2026-2032年市场预测（依产品类型、手术方法、年龄层、性别、通路和最终用户划分）

Surgical Sphincteroplasty Market by Product Type, Technique, Age Group, Gender, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科括约肌成形术市场价值将达到 17 亿美元，到 2026 年将成长至 17.8 亿美元，复合年增长率为 9.59%，到 2032 年将达到 32.3 亿美元。

主要市场统计数据
基准年 2025 17亿美元
预计年份：2026年 17.8亿美元
预测年份 2032 32.3亿美元
复合年增长率 (%) 9.59%

对外科括约肌成形术进行简要概述，重点关注不断发展的材料、手术路径以及临床医生和采购经理之间的通用优先事项。

括约肌成形术在泌尿系统重组和结直肠外科的交叉领域占据着至关重要的地位，它透过靶向解剖修復来解决括约肌功能障碍。缝合技术、移植材料和手术方法的进步拓展了临床选择，也使得实证材料和手术方案的选择更加重要。目前，医疗专业人员在选择可吸收和不可吸收材料时，会考虑其生物相容性、抗张性能和长期组织整合情况，而患者的合併症、年龄和手术史在决定手术方案方面也日益重要。

材料创新、外科技术改进和医疗保健服务的进步如何重塑括约肌成形术的临床选择和商业性定位。

外科括约肌成形术领域正经历一场变革，其驱动力来自于材料创新、手术技术改进以及医疗服务模式的转变。新型可吸收和不可吸收缝合线配方以及生物基和合成移植物的应用，改变了术中选择和术后结果，迫使外科医生在即时机械修復与长期组织反应之间寻求平衡。同时，从即时一期修復策略到延迟二次手术以及各种迭加结构，手术技术的进步正在拓展临床医生可选择的手术方案。

2025 年美国关税调整对括约肌重建手术器械的供应链、筹资策略和临床可用性的综合影响。

关税政策和贸易措施的变化会对整个外科手术供应链产生连锁反应，影响括约肌成形术相关产品的成本、筹资策略和分销模式。 2025年，主要市场关税和进口税的调整迫使製造商和经销商重新评估製造地和物流策略。同时，医疗采购团队也重新审视了与供应商的关係，以维持成本稳定和临床服务的连续性。这些趋势使得采购管道多元化以及对到货成本（除表面价格外）的更深入了解变得更加重要。

细分市场层面的洞察揭示了产品类型、手术技术、最终用户特征、分销管道和患者人口统计特征如何决定策略重点。

细分市场趋势揭示了不同的需求驱动因素，这些因素指南产品开发、临床应用和分销策略。按产品类型划分，该市场包括可吸收缝线、植入材料和网片解决方案（包括氧环己酮聚合体和聚乙醇酸衍生物），以及尼龙和聚丙烯等不可吸收缝线。每种材料类别都有其独特的操作特性、组织反应特征和外科医生偏好，这些因素反过来又会影响培训需求和库存计划。当组织重塑是首要考虑因素时，可吸收材料往往是首选；而当需要长期张力支撑时，不可吸收材料仍然是首选。

区域趋势和医疗保健系统特征决定了全球市场的监管策略、临床引入模式和分销重点。

区域趋势差异显着，进而影响研究重点、监理路径和商业化策略。在美洲，成熟的临床卓越中心和完善的采购体系创造了竞争环境，实证差异化和服务模式决定了医疗资源的取得和推广。医保报销机制和区域专科中心集中了需求，而本地生产和经销伙伴则影响着供应的可靠性。

重新定义括约肌成形术的製造商策略、临床伙伴关係与价值主导差异化：竞争与合作的力量

外科括约肌成形术领域的竞争格局由成熟的医疗设备製造商、新兴的专业公司以及致力于累积实证医学证据和改进技术的临床联盟共同构成。大型成熟企业凭藉其广泛的分销网络和整合的临床培训项目，在医院和门诊管道保持着稳固的地位。另一方面，专业製造商则透过材料科学的创新和针对特定手术的客製化解决方案来脱颖而出。Start-Ups和利基创新者通常专注于新型移植物配方和缝合技术，旨在解决特定的失效模式或简化手术流程。

为製造商、临床领导者和采购团队制定的切实可行的行动计划，旨在协调证据计划、供应弹性和通路策略，以实现永续成长。

产业领导者应着重采取一系列切实可行的措施，使商业策略与临床实际情况和供应链韧性相契合。优先投资于强有力的临床证据项目，以比较不同材料类型和手术方式的治疗效果，并增强外科医生采用新材料所需的信心。同时，透过供应商多元化、协商灵活的合约机制以及探索区域性製造和组装来优化供应链，从而保护企业免受贸易中断的影响。

我们透明、多方面的调查方法，结合了对临床医生的访谈、监管审查和供应链分析，支持可操作的见解和可重复的研究结果。

本研究整合了来自同行评审临床文献、相关人员访谈、监管文件和供应链分析的交叉检验讯息，以确保其具有全面且检验的基础。主要研究包括与执业外科医生、采购经理和分销合作伙伴进行结构化讨论，以收集有关器械操作、库存流动和医疗保健优先事项的第一手资讯。二级资讯来源包括临床试验库、器械註册库和公开的监管文件，以支援临床性能和器械分类。

对决定括约肌成形术实施的成功和可持续价值的临床、商业性和价值链因素进行前瞻性整合。

括约肌成形术正处于材料科学、外科技术创新和不断变化的医疗服务模式的交汇点，这既带来了临床机会，也带来了商业性的挑战。将严谨的临床证据与灵活的供应和分销策略相结合的相关人员，将更有能力满足临床医生的期望和医疗采购需求。外科技术的进步和门诊环境的扩展凸显了对操作可预测、疗效可靠且可扩展分销的医疗设备的需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科括约肌成形术市场：依产品类型划分

  • 可吸收缝线
    • 氧环己酮聚合体
    • 聚乙醇酸
  • 接枝
  • 网
  • 不可吸收缝线
    • 尼龙
    • 聚丙烯

第九章 外科括约肌成形术市场：依技术划分

  • 延迟二次法
  • 即时原发性手术
  • 重迭法
    • 从头到尾
    • 左右

第十章 外科括约肌成形术市场：依年龄组别划分

  • 成人版
  • 老年人
  • 儿童

第十一章 外科括约肌成形术市场：性别

  • 女士
  • 男性

第十二章 外科括约肌成形术市场：依通路划分

  • 直销
    • 销售代理
    • 製造商
  • 医院采购
  • 在线的
    • B2B电子商务
    • B2C

第十三章 外科括约肌成形术市场：依最终使用者划分

  • 门诊手术中心
    • 独立的
    • 医院附属机构
  • 医院和诊所
    • 私人的
    • 民众

第十四章 外科括约肌成形术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 外科括约肌成形术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 外科括约肌成形术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国外科括约肌成形术市场

第十八章 中国外科括约肌成形术市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical LLC
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Novo Surgical, Inc.
  • Olympus Corporation
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • The Cooper Companies, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3A2E844FE1EC

The Surgical Sphincteroplasty Market was valued at USD 1.70 billion in 2025 and is projected to grow to USD 1.78 billion in 2026, with a CAGR of 9.59%, reaching USD 3.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.70 billion
Estimated Year [2026] USD 1.78 billion
Forecast Year [2032] USD 3.23 billion
CAGR (%) 9.59%

A concise orientation to surgical sphincteroplasty emphasizing evolving materials, surgical pathways, and the converging priorities of clinicians and procurement leaders

Surgical sphincteroplasty occupies a pivotal position at the intersection of reconstructive urology and colorectal surgery, addressing sphincter dysfunction through targeted anatomical repair. Advances in suture technology, graft materials, and operative techniques have expanded clinical options and raised the importance of evidence-based selection of materials and approaches. Practitioners now weigh biocompatibility, tensile properties, and long-term integration when choosing between absorbable and nonabsorbable materials, while procedural decision-making increasingly incorporates patient comorbidity, age, and prior surgical history.

As the clinical community integrates minimally invasive adjuncts and refines perioperative protocols, the role of ambulatory surgical centers alongside traditional hospital settings has grown. This shift underscores the need for surgeons, procurement professionals, and product developers to align around cost-effective care pathways, predictable outcomes, and streamlined supply chains. Consequently, a nuanced understanding of product attributes, technique-specific outcomes, and end-user logistics is essential for stakeholders seeking to optimize clinical efficacy and commercial performance in this specialized surgical domain.

How innovations in materials, procedural refinements, and care delivery evolution are reshaping clinical choices and commercial positioning in sphincteroplasty

The landscape of surgical sphincteroplasty is experiencing transformative shifts driven by material innovation, procedural refinement, and changing care delivery models. Novel absorbable and nonabsorbable suture formulations alongside biologic and synthetic grafts have altered intraoperative choices and postoperative expectations, prompting surgeons to balance immediate mechanical repair with long-term tissue response. Concurrently, refinements in surgical technique-ranging from immediate primary repair strategies to delayed secondary interventions and various overlapping configurations-have broadened the procedural toolkit available to clinicians.

In parallel, the growth of ambulatory surgical centers and the increasing sophistication of hospital procurement practices have recalibrated distribution and purchasing dynamics. These care-delivery transformations elevate the importance of device ease-of-use, inventory predictability, and total procedure cost. Moreover, heightened regulatory scrutiny and an emphasis on value-based outcomes are compelling manufacturers and clinical teams to substantiate product performance through rigorous evidence generation and post-market surveillance, thereby reshaping how new technologies enter and scale within clinical practice.

The compound implications of United States tariff adjustments in 2025 on supply chains, procurement strategies, and clinical availability for sphincteroplasty devices

Tariff policy changes and trade measures can create ripple effects across surgical supply chains, influencing costs, sourcing strategies, and distribution models for sphincteroplasty-related products. In 2025, adjustments to tariffs and import duties in key markets prompted manufacturers and distributors to reassess manufacturing footprints and logistics strategies, while procurement teams in healthcare institutions revisited supplier relationships to preserve cost stability and clinical continuity. These developments reinforced the need for diversified sourcing and clearer visibility into landed costs beyond headline prices.

Consequently, many organizations intensified efforts to localize components, negotiate fixed-price agreements, and leverage centralized procurement vehicles to mitigate exposure to tariff volatility. For clinical stakeholders, these commercial shifts translated into evolving product availability patterns and a renewed emphasis on product equivalence assessments. Looking ahead, resilience in the supply chain will increasingly hinge on flexible manufacturing strategies, expanded regional supplier bases, and collaborative contracting approaches that minimize disruption while supporting consistent patient care.

Segment-level insights revealing how product types, surgical techniques, end-user characteristics, distribution channels, and patient demographics direct strategic priorities

Segment-level dynamics reveal differentiated demand drivers that inform product development, clinical adoption, and distribution strategies. Based on product type, the landscape encompasses absorbable sutures, including polydioxanone and polyglycolic acid variants, graft materials, mesh solutions, and nonabsorbable sutures such as nylon and polypropylene. Each material class presents distinct handling characteristics, tissue response profiles, and surgeon preferences, which in turn influence training requirements and inventory planning. Absorbable alternatives often appeal where tissue remodeling is prioritized, whereas nonabsorbable options retain favor in scenarios demanding long-term tensile support.

Technique-based segmentation shows meaningful implications for device design and clinical training, with delayed secondary approaches, immediate primary repairs, and overlapping techniques-further delineated into end-to-end and side-to-side configurations-demanding specific instrument ergonomics and suture performance. End users shape procurement cadence and product configuration needs, as ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize streamlined kits and rapid turnover while hospitals, both private and public, emphasize broad product portfolios and contract compliance. Distribution channels likewise affect market access and service models: direct sales through distributors or manufacturers, hospital procurement via direct purchases or group purchasing organizations, and online avenues spanning B2B ecommerce and B2C platforms each require tailored commercial strategies. Patient demographics add another layer of granularity, with adult, geriatric, and pediatric populations presenting differing anatomical and healing characteristics, and gender considerations between female and male patients influencing clinical decision-making and outcome measurement. Taken together, these segmentation perspectives should guide targeted clinical evidence generation, differentiated product positioning, and channel-specific commercial planning.

Regional dynamics and healthcare system nuances that determine regulatory strategy, clinical adoption patterns, and distribution priorities across global markets

Regional dynamics vary substantially and shape research priorities, regulatory pathways, and commercialization tactics. In the Americas, established centers of clinical excellence and mature procurement frameworks create a competitive environment where evidence-based differentiation and service models determine access and uptake. Reimbursement structures and regional centers of expertise concentrate demand, while localized manufacturing and distribution partnerships influence supply reliability.

Across Europe, Middle East & Africa, heterogeneous regulatory regimes and variable healthcare funding mechanisms necessitate adaptive market entry strategies that account for national-level tenders, clinical adoption cycles, and differing hospital capabilities. Strategic partnerships and region-specific clinical data often accelerate acceptance in diverse health systems. In the Asia-Pacific, rapid expansion of surgical capacity, investments in ambulatory surgical infrastructure, and a growing emphasis on minimally disruptive care pathways are driving demand for versatile, cost-effective solutions. Local manufacturing initiatives and regional regulatory harmonization efforts further affect product availability and competitive dynamics. Together, these regional patterns underscore the importance of tailoring clinical evidence, pricing, and distribution to local system characteristics to achieve sustainable adoption.

Competitive and collaborative forces redefining manufacturer strategies, clinical partnerships, and value-driven differentiation in sphincteroplasty

Competitive landscapes in surgical sphincteroplasty are shaped by a mix of legacy medical device firms, emerging specialized manufacturers, and clinical consortia focused on evidence development and technique refinement. Established players leverage deep distribution networks and integrated clinical training programs to maintain visibility in hospital and ambulatory channels, while specialized manufacturers differentiate through material science innovations and targeted procedural solutions. Start-ups and niche innovators often focus on novel graft formulations or suture technologies designed to address specific failure modes or to simplify operative workflow.

Collaborations between clinical centers and commercial partners have become more frequent, producing real-world evidence and procedural refinements that accelerate adoption. At the same time, strategic partnerships with distributors, group purchasing organizations, and ecommerce platforms expand market reach but require alignment on service levels and value-based contracting. For market entrants and incumbents alike, sustained competitive advantage is increasingly tied to demonstrable clinical outcomes, robust post-market surveillance, and the ability to integrate educational support into the customer value proposition.

Practical action plans for manufacturers, clinical leaders, and procurement teams to align evidence programs, supply resilience, and channel strategies for sustainable growth

Industry leaders should focus on a set of pragmatic actions that align commercial strategy with clinical realities and supply chain resilience. Prioritize investment in robust clinical evidence programs that compare material classes and technique-specific outcomes to give surgeons the confidence needed for adoption. In parallel, optimize supply arrangements by diversifying supplier bases, negotiating flexible contracting mechanisms, and exploring regional manufacturing or assembly to insulate against trade-related disruptions.

Commercial teams ought to tailor channel strategies to end-user needs: develop streamlined procedural kits and rapid-replenishment models for ambulatory surgical centers while offering comprehensive portfolio and compliance solutions for hospital systems. Embrace digital channels for customer engagement and product education, and ensure that ecommerce and direct-sales models integrate with hospital procurement processes. Finally, invest in post-market surveillance and clinician-facing training to demonstrate long-term value, reduce adverse outcomes, and foster clinical champions who can validate product performance in real-world settings.

A transparent, multi-source research methodology combining clinician interviews, regulatory review, and supply chain analysis to underpin actionable insights and reproducible findings

This research synthesizes triangulated inputs from peer-reviewed clinical literature, stakeholder interviews, regulatory documentation, and supply chain analyses to ensure a comprehensive and verifiable foundation. Primary research included structured discussions with practicing surgeons, procurement leads, and distribution partners to capture experiential insights on device handling, inventory flows, and institutional priorities. Secondary sources comprised clinical trial repositories, device registries, and publicly available regulatory filings to corroborate clinical performance and device classifications.

Analytical methods integrated qualitative coding of interview data with thematic trend analysis to identify recurring drivers of adoption and barriers to scale. Supply chain assessments applied scenario modeling to evaluate procurement sensitivity to tariff shifts, while competitive mapping examined product portfolios, channel footprints, and collaboration patterns. Throughout, emphasis was placed on transparency of assumptions and traceability of sources, and readers are directed to the methodology appendices for detailed interview counts, search protocols, and document inventories that support reproducibility and validation of the findings.

A forward-looking synthesis of clinical, commercial, and supply chain factors that will determine successful adoption and sustained value in sphincteroplasty

Surgical sphincteroplasty is evolving at the confluence of material science, surgical technique innovation, and shifting care delivery models, presenting both clinical opportunities and commercial complexity. Stakeholders who integrate rigorous clinical evidence with adaptive supply and channel strategies will be best positioned to meet clinician expectations and institutional procurement needs. The year-on-year procedural refinements and growth of ambulatory settings underscore the need for devices that offer predictable handling, robust outcomes, and scalable distribution.

As regulatory environments and trade policies continue to influence product movement and pricing, resilience through diversified sourcing and validated clinical performance will become central to sustainable adoption. Ultimately, the future of sphincteroplasty will favor those who can demonstrate clear patient benefits, support clinicians with practical training and evidence, and align commercial operations to the nuanced requirements of hospitals, ambulatory centers, and digital procurement channels.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Sphincteroplasty Market, by Product Type

  • 8.1. Absorbable Sutures
    • 8.1.1. Polydioxanone
    • 8.1.2. Polyglycolic Acid
  • 8.2. Graft
  • 8.3. Mesh
  • 8.4. Nonabsorbable Sutures
    • 8.4.1. Nylon
    • 8.4.2. Polypropylene

9. Surgical Sphincteroplasty Market, by Technique

  • 9.1. Delayed Secondary Technique
  • 9.2. Immediate Primary Technique
  • 9.3. Overlapping Technique
    • 9.3.1. End-To-End
    • 9.3.2. Side-To-Side

10. Surgical Sphincteroplasty Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Surgical Sphincteroplasty Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Surgical Sphincteroplasty Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. Distributor
    • 12.1.2. Manufacturer
  • 12.2. Hospital Procurement
  • 12.3. Online
    • 12.3.1. B2B Ecommerce
    • 12.3.2. B2C

13. Surgical Sphincteroplasty Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Freestanding
    • 13.1.2. Hospital-Affiliated
  • 13.2. Hospitals & Clinics
    • 13.2.1. Private
    • 13.2.2. Public

14. Surgical Sphincteroplasty Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Sphincteroplasty Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Sphincteroplasty Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Sphincteroplasty Market

18. China Surgical Sphincteroplasty Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Coloplast A/S
  • 19.11. ConMed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Hologic, Inc.
  • 19.14. Integra LifeSciences Holdings Corporation
  • 19.15. Intuitive Surgical, Inc.
  • 19.16. Johnson & Johnson
  • 19.17. Medtronic plc
  • 19.18. Merit Medical Systems, Inc.
  • 19.19. Novo Surgical, Inc.
  • 19.20. Olympus Corporation
  • 19.21. Smith & Nephew PLC
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. The Cooper Companies, Inc.
  • 19.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 239. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 240. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 244. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 281. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 282. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 286. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 295. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 296. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 300. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 303. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES SURGICAL SPHINC